Pilot study of hepatitis b, c and human immunodeficiency viruses infections among patients with chronic liver diseases from north-east india attending a new tertiary care health set up at shillong

Background:  Chronic liver diseases (CLD) are major public health concerns in North-Eastern India. Association of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections in CLD patients result in atypical presentations with increased severity and duration of illness. Understanding of agent, host, clinical profiles and their co-relationship for better management and prevention of such diseases in the community are important challenges.  Aims:  To assess sero-prevalance of HBV, HCV, HIV and their co-infection/triple infection in CLD patients from North-East India. To determine risk factors predisposing to development of CLDs. To find out if any correlation exists between risk factors for CLDs and that of HBV/HCV/HIV infections.  Materials And Methods:  This study was conducted from December 2009 to June 2011 in North-Eastern Indira Gandhi Regional Institute of Health and Medical Sciences. Blood samples were collected from 57 clinically diagnosed CLD patients after obtaining Institutional ethical clearance. Detail clinical profile with relevant biochemical test results were recorded. Viral markers - hepatitis B surface antigen, hepatitis B e (HBe) antigen, anti-HBe and anti-HCV were assessed employing commercial ELISA kits. Specimens were subjected for detection and confirmation of HIV infection as per NACO Guidelines.  Results:  Male to female ratio was 1.85:1 with most cases in range of 31-50 years. HBV markers were detected in 35 (61.40%) and anti-HCV in 2 (3.5%) patients. Anti-HIV was reactive in 7 (12.28%) patients; 4 co-infected with HBV and 2 with HCV.  Conclusion:  HBV is still a major cause of CLD, followed by HCV in North-East India. Co-infection of HBV/HCV with HIV was low (7.14%) in comparison to rest of India. Confections of HIV with HBV/HCV in CLDs patients was observed to be major public health concern in terms of risk factors and transmission dynamics of these chronic diseases in North-East India. Â

[1]  A. Kim Hepatitis C Virus , 2016, Annals of Internal Medicine.

[2]  M. Malhotra,et al.  Hepatitis B and C Positivity in Various Categories of Human Immunodeficiency Virus Seropositive Individuals in a Regional STD Centre-an Eight-Year Evaluation of Trends and Risk Factors , 2010 .

[3]  A. Pieri,et al.  Fatal reactivation of HBV and HDV during a long-lasting interruption of HAART in a patient co-infected with HIV, HCV, HBV and HDV. , 2010, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

[4]  A. Chakravarti,et al.  Seroprevalence of hepatitis viruses in patients infected with the human immunodeficiency virus. , 2009, Indian journal of pathology & microbiology.

[5]  S. Datta An overview of molecular epidemiology of hepatitis B virus (HBV) in India , 2008, Virology Journal.

[6]  M. J. van de Laar,et al.  Surveillance and epidemiology of hepatitis B and C in Europe - a review. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  H. Changotra,et al.  Diagnosing different stages of hepatitis B infection using a competitive polymerase chain reaction assay. , 2008, Indian journal of medical microbiology.

[8]  Manjula Jain,et al.  Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study. , 2007, Japanese journal of infectious diseases.

[9]  M. Yuen,et al.  Hepatitis B Virus Core-Related Antigens as Markers for Monitoring Chronic Hepatitis B Infection , 2007, Journal of Clinical Microbiology.

[10]  Alexandra Valsamakis,et al.  Molecular Testing in the Diagnosis and Management of Chronic Hepatitis B , 2007, Clinical Microbiology Reviews.

[11]  A. Mann,et al.  Prevalence of hepatitis B virus hepatitis C virus and HIV in patients of chronic liver disease in Amritsar. , 2007 .

[12]  Sarman Singh,et al.  Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients. , 2006, World journal of gastroenterology.

[13]  N. Mishra,et al.  Prevalence of parenterally transmitted hepatitis viruses in clinically diagnosed cases of hepatitis. , 2005, Indian journal of medical microbiology.

[14]  A. Chakravarti,et al.  Prevalence of hepatitis C and B viral markers in patients with chronic liver disease: a study from Northern India. , 2005, Indian journal of medical microbiology.

[15]  D. Rawat,et al.  A study on the perinatal transmission of the hepatitis B virus. , 2005, Indian journal of medical microbiology.

[16]  I. Shukla,et al.  Need for routine screening of HBV and HDV in patients with cirrhosis of the liver. , 2005, Indian journal of medical microbiology.

[17]  D. Bhasin,et al.  Study of hepatitis B and C viral markers in patients of chronic liver disease. , 2004, Indian journal of medical microbiology.

[18]  A. Hamide,et al.  Co-infection with hepatitis C virus and human immunodeficiency virus among patients with sexually transmitted diseases in Pondicherry, South India. , 2003, Indian Journal of Pathology and Microbiology.

[19]  A. Kumar,et al.  Co-infection with hepatitis B and human immunodeficiency viruses in patients of liver disease. , 2003, Indian journal of medical microbiology.

[20]  M. Rele,et al.  Prevalence of HIV infection in HBsAg positive cases. , 2002, Indian journal of medical microbiology.

[21]  P. Chou,et al.  Comparison of hepatitis B virus and hepatitis C virus prevalence and risk factors in a community-based study. , 2002, The American journal of tropical medicine and hygiene.

[22]  S. Yagi,et al.  Sensitive Enzyme Immunoassay for Hepatitis B Virus Core-Related Antigens and Their Correlation to Virus Load , 2002, Journal of Clinical Microbiology.

[23]  Bernard Weber,et al.  Improved Detection of Hepatitis B Virus Surface Antigen by a New Rapid Automated Assay , 1999, Journal of Clinical Microbiology.

[24]  F. Locatelli,et al.  Nephrology Dialysis Transplantation Hepatitis C Virus Infection and Acute or Chronic Glomerulonephritis: an Epidemiological and Clinical Appraisal , 2022 .

[25]  L. Dai,et al.  A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. , 1998, International journal of epidemiology.

[26]  Max Sussman,et al.  Topley and Wilson's Microbiology and Microbial infections , 1998 .

[27]  M. Ho,et al.  Hepatitis C markers in hemodialysis patients , 1993, Journal of clinical microbiology.

[28]  E. A. Ayoola,et al.  Prevalence of antibodies to hepatitis C virus among Saudi patients with chronic liver diseases. , 1992, Hepato-gastroenterology.

[29]  F. Zoulim,et al.  New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection , 1992, Journal of clinical microbiology.

[30]  L. Mimms,et al.  Serological markers of posttransfusion hepatitis C viral infection , 1992, Journal of clinical microbiology.